Glioblastoma and a recurrence. What should I do

July 9, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

I'm sorry you're facing a recurrence. This is a serious situation that requires personalized medical guidance from your oncology team.

What I can tell you about recurrent glioblastoma:

According to the Musella Foundation's Brain Tumor Guide, recurrent glioblastoma typically involves re-evaluation of your tumor's characteristics and consideration of several approaches:

  • Surgery may be considered if the tumor is resectable (can be safely removed)
  • GammaTiles (biodegradable wafers that release radiation) are FDA-approved for recurrent GBM and showed median survival of 18 months in published data—compared to the typical 5-7 months expected for recurrent disease
  • Genomic testing of the recurrent tumor to identify any new mutations that might respond to targeted therapies
  • Immunotherapy options like checkpoint inhibitors (Keytruda) or other immunotherapies
  • Chemotherapy (temozolomide) if your tumor is MGMT methylated
  • Clinical trials may offer access to newer treatments

What you need to do now:

  1. Meet with your oncology team to discuss your specific recurrence—location, size, and molecular characteristics matter enormously
  2. Ask about genomic testing of the recurrent tumor tissue
  3. Discuss all available options including surgery, radiation approaches, and clinical trials
  4. Consider a second opinion from a GBM specialist, ideally at an NCI-designated cancer center

The Musella Foundation (virtualtrials.org) and Cancer Commons both offer free resources to help patients navigate recurrent brain cancer options.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2